Medine.co.uk

Bells Corn & Callus Ointment

Informations for option: Bells Corn & Callus Ointment, show other option

SUMMARY OF PRODUCT CHARACTERISTICS

1 NAME OF THE MEDICINAL PRODUCT

BELL’S CORN & CALLUS OINTMENT

2 QUALITATIVE AND QUANTITATIVE COMPOSITION

Salicylic Acid BP 12.5 % w/w

3 PHARMACEUTICAL FORM

OINTMENT

4 CLINICAL PARTICULARS

4.1 Therapeutic indications

A remedy to aid in the removal of corns, callouses and hard skin.

4.2 Posology and method of administration

Adults, Elderly and Children: Apply to the affected small areas of the feet at bedtime. Cover them if necessary. Wash in warm to hot water in the morning.

4.3 Contraindications

Contraindicated in patients known to be sensitive to Salicylic Acid and also those who suffer from asthma.

Bell’s Corn & Callus Ointment should not be used by diabetics or patients with impaired blood circulation. Do not use if the corn or callous or surrounding skin is inflamed or broken. Do not use on moles, birthmarks, unusual warts with hair growth, on facial warts, or in the anal or perineal region.

4.4 Special warnings and precautions for use

Bell’s Corn & Callus Ointment is for external use only. Do not permit contact with eyes or mucous membranes. If contact occurs flush with water for 15 minutes. Do not allow contact with normal skin around corn or callous. Avoid using on areas of broken or damaged skin. Discontinue treatment if excessive irritation occurs. Excessive prolonged use of topical salicylic acid may result in symptoms of salicylism and must therefore be avoided.

Keep medicines away from children. Wash hands after use.

4.5 Interaction with other medicinal products and other forms of interaction

None.

4.6 Pregnancy and lactation

May be used.

4.7 Effects on ability to drive and use machines

None.

4.8 Undesirable effects

May cause hypersensitivity reactions, skin rashes and dermatitis.

Undesirable effects are listed by MEDRA System Organ Classes.

Assessment of undesirable effects is based on the following frequency groupings:

Very common: >1/10

Common:>1/100 to <1/10

Uncommon:>1/1000 to <1/100

Rare:> 1/10000 to <1/1000

Very rare:<1/10000

Not known: cannot be estimated from the available data

System Organ Class


Undesirable Effect


Frequency


*A localised irritant reaction may occur if Bell’s Corn & Callus Ointment is applied to normal skin surrounding the corn or callous. This may normally be controlled by temporarily discontinuing the use of Bell’s Corn & Callus Ointment and by being careful to apply the solution only to the corn or callous itself when treatment is resumed.

Reporting of suspected adverse reactions

Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard.

4.9    Overdose

Symptoms of systemic salicylate poisoning have been reported after the application of salicylic acid to large areas of skin and for prolonged periods. Salicylism may also occur in the unlikely event of large quantities being ingested. Salicylism is unlikely to occur if Bell’s Corn & Callus Ointment is used as indicated.

5    PHARMACOLOGICAL PROPERTIES

5.1 Pharmacodynamic properties

Salicylic Acid is keratolytic.

5.2 Pharmacokinetic properties

No information available.

5.3


Skin and subcutaneous tissue disorders

Skin irritation*

Not known

Injury, poisoning and procedural complications

Salicylism (including tinnitus)

Not known


Preclinical safety data

No information available.

6.1 List of excipients

Maize Starch, Liquid Paraffin, Chlorophyll Oil-Soluble, Yellow Soft Paraffin.

6.2 Incompatibilities

None.

6.3 Shelf life

Three years.

6.4 Special precautions for storage

None.

6.5 Nature and contents of container

Glass jar with wadded hard plastic screwcap: 25 g. Double-wall polyethylene pot with hard plastic screwcap: 25 g.

6.6 Special precautions for disposal

Not applicable.

7 MARKETING AUTHORISATION HOLDER

Bell Sons and Company (Druggist) Limited

Gifford House

Slaidburn Crescent

Southport

Merseyside

PR9 9AL

United Kingdom

MARKETING AUTHORISATION NUMBER(S)

PL 03105/0084

9


10


DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION

29/05/1990

DATE OF REVISION OF THE TEXT

08/11/2016